The effect of cadmium on Aβ levels in APP/PS1 transgenic mice

Experimental and Therapeutic Medicine

Volumn 4, Issue 1, 2012, Pages 125-130

  Li, Xiaoling ^a,b   Lv, Yongli ^a   Yu, Song ^c   Zhao, Haihua ^a   Yao, Lijie ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b QIQIHAR MEDICAL UNIVERSITY   (China)

^c LIAONING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

secretase; Alzheimer's disease; Amyloid precursor protein; Cadmium; Neutral endopeptidase; Soluble amyloid precursor protein ; Zinc

Indexed keywords

ADAM10 ENDOPEPTIDASE; ALPHA SECRETASE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; CADMIUM; MEMBRANE METALLOENDOPEPTIDASE; PRESENILIN 1; ZINC;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOMETALLOGRAPHY; BEHAVIOR CHANGE; BRAIN CORTEX; BRAIN LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LEARNING; MALE; MAZE TEST; MEMORY; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TRANSGENIC MOUSE; WESTERN BLOTTING;

EID: 84865708686     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.562     Document Type: Article

References (26)

1. 2+ currents are mediated by calcium-permeable AMPA/kainate channels in cultured murine hippocampal neurones. J Physiol 543: 35-48, 2002.
2. Koh JY and Choi DW: Zinc toxicity on cultured cortical neurons: involvement of N-methyl-D-aspartate receptors. Neuroscience 60: 1049-1057, 1994.
3. Palmiter RD and Findley SD: Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc. EMBO J 14: 639-649, 1995.
4. Rogers EE, Eide DJ and Guerinot ML: Altered selectivity in an Arabidopsis metal transporter. Proc Natl Acad Sci USA 97: 12356-12360, 2000.
5. Vallee BL and Auld DS: Zinc coordination, function, and structure of zinc enzymes and other proteins. Biochemistry 29: 5647-5659, 1990.
6. Vallee BL and Falchuk KH: The biochemical basis of zinc physiology. Physiol Rev 73: 79-118, 1993.
7. Wu X, Jin T, Wang Z, Ye T, Kong Q and Nordberg G: Urinary calcium as a biomarker of renal dysfunction in a general population exposed to cadmium. J Occup Environ Med 43: 898-904, 2001.
8. Lui E, Fisman M, Wong C and Diaz F: Metals and the liver in Alzheimer's disease. An investigation of hepatic zinc, copper, cadmium, and metallothionein. J Am Geriatr Soc 38: 633-639, 1990.
9. Panayi AE, Spyrou NM, Iversen BS, White MA and Part P: Determination of cadmium and zinc in Alzheimer's brain tissue using inductively coupled plasma mass spectrometry. J Neurol Sci 195: 1-10, 2002.
10. Lambert MP, Barlow AK, Chromy BA, et al: Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95: 6448-6453, 1998.
11. Torreilles F and Touchon J: Pathogenic theories and intrathecal analysis of the sporadic form of Alzheimer's disease. Prog Neurobiol 66: 191-203, 2002.
12. Bressler JP, Olivi L, Cheong JH, Kim Y, Maerten A and Bannon D: Metal transporters in intestine and brain: their involvement in metal-associated neurotoxicities. Hum Exp Toxicol 26: 221-229, 2007.
13. Jomova K and Valko M: Advances in metal-induced oxidative stress and human disease. Toxicology 283: 65-87, 2011.
14. Jiang LF, Yao TM, Zhu ZL, Wang C and Ji LN: Impacts of Cd(II) on the conformation and self-aggregation of Alzheimer's tau fragment corresponding to the third repeat of microtubulebinding domain. Biochim Biophys Acta 1774: 1414-1421, 2007.
15. Danscher G, Jensen KB, Frederickson CJ, et al: Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains: a proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material. J Neurosci Methods 76: 53-59, 1997.
16. Bush AI, Pettingell WH, Multhaup G, et al: Rapid induction of Alzheimer A beta amyloid formation by zinc. Science 265: 1464-1467, 1994.
17. Liu ST, Howlett G and Barrow CJ: Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the A beta peptide of Alzheimer's disease. Biochemistry 38: 9373-9378, 1999.
18. Danscher G, Stoltenberg M, Bruhn M, Sondergaard C and Jensen D: Immersion autometallography: histochemical in situ capturing of zinc ions in catalytic zinc-sulfur nanocrystals. J Histochem Cytochem 52: 1619-1625, 2004.
19. Jung KM, Astarita G, Yasar S, et al: An amyloid beta(42) dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimer's disease. Neurobiol Aging: May 3, 2011 (Epub ahead of print).
20. Endres K and Fahrenholz F: The role of the anti-amyloidogenic secretase ADAM10 in shedding the APP-like proteins. Curr Alzheimer Res: May 23, 2011 (Epub ahead of print).
21. Hook VY and Reisine TD: Cysteine proteases are the major betasecretase in the regulated secretory pathway that provides most of the beta-amyloid in Alzheimer's disease: role of BACE 1 in the constitutive secretory pathway. J Neurosci Res 74: 393-405, 2003.
22. Iwata N and Saido TC: Amyloid-beta peptide metabolism and Alzheimer's disease. Nihon Yakurigaku Zasshi 122: 5-14, 2003.
23. Leissring MA, Farris W, Chang AY, et al: Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40: 1087-1093, 2003.
24. Iwata N, Mizukami H, Shirotani K, et al: Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-beta peptide in mouse brain. J Neurosci 24: 991-998, 2004.
25. Marr RA, Rockenstein E, Mukherjee A, et al: Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J Neurosci 23: 1992-1996, 2003.
26. Sakai A, Ujike H, Nakata K, et al: Association of the neprilysin gene with susceptibility to late-onset Alzheimer's disease. Dement Geriatr Cogn Disord 17: 164-169, 2004.